PTHS - Pelthos Therapeutics Inc.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 26.97 1.14 (4.23%) | --- | --- | --- | --- | 1.14 (4.23%) | --- | --- |
Pelthos Therapeutics Inc is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- Diluted EPS:
- Basic P/E:
- Diluted P/E:
- RSI(14) 1m:
- 100.0
- VWAP:
- 28.02
- RVol:
- 0.932
Events
| Period | Kind | Movement | Occurred At |
|---|---|---|---|
| 60m | Price increase 60m | 28.11 +1.51 (+5.68%) | Oct 15 15:44 |
| 1m | Price increase 1m | 28.0 +0.61 (+2.23%) | Oct 15 11:18 |
| 1m | Price increase 1m | 27.39 +0.6 (+2.24%) | Oct 15 10:37 |